Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: Future therapeutic targets

被引:43
作者
Kraneveld, Aletta D. [1 ]
Rijnierse, Anneke [2 ]
Nijkamp, Frans P. [1 ]
Garssen, Johan [1 ]
机构
[1] Univ Utrecht, Div Pharmacol & Pathophysiol, Utrecht Inst Pharmaceut Sci, Fac Sci, NL-3508 TB Utrecht, Netherlands
[2] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, Wageningen, Netherlands
关键词
inflammatory bowel disease; irritable bowel syndrome; neuro-immune interaction; NANC nerve; cytokine; chemokine; Toll-like receptor; immunoglobulin;
D O I
10.1016/j.ejphar.2008.02.095
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The gastro-intestinal tract is well known for its largest neural network outside the central nervous system and for the most extensive immune system in the body. Research in neurogastroenterology implicates the involvement of both enteric nervous system and immune system in symptoms of inflammatory bowel disease and irritable bowel syndrome. Since both disorders are associated with increased immune cell numbers, nerve growth and activation of both immune cells and nerves, we focus in this review on the involvement of immune cell-nerve interactions in inflammatory bowel disease and irritable bowel syndrome. Firstly, the possible effects of enteric nerves, especially of the nonadrenergic and noncholinergic nerves, on the intestinal immune system and their possible role in the pathogenesis of chronic intestinal inflammatory diseases are described. Secondly, the possible effects of immunological factors, from the innate (chemokines and Toll-like receptors) as well as the adaptive (cytokines and immunoglobulins) immune system, on gastro-intestinal nerves and its potential role in the development of inflammatory bowel disease and irritable bowel syndrome are reviewed. investigations of receptor-mediated and intracellular signal pathways in neuro-immune interactions might help to develop more effective therapeutic approaches for chronic inflammatory intestinal diseases. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:361 / 374
页数:14
相关论文
共 182 条
[51]   Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease [J].
Gordon, John N. ;
Pickard, Karen M. ;
Di Sabatino, Antonio ;
Prothero, Joanna D. ;
Pender, Sylvia L. F. ;
Goggin, Patrick M. ;
MacDonald, Thomas T. .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (02) :195-203
[52]   Fundamentals of neurogastroenterology:: Basic science [J].
Grundy, David ;
Al-Chaer, Elie D. ;
Aziz, Qasim ;
Collins, Stephen M. ;
Ke, Meiyun ;
Tache, Yvette ;
Wood, Jackie D. .
GASTROENTEROLOGY, 2006, 130 (05) :1391-1411
[53]   Probiotic agents in the treatment of irritable bowel syndrome [J].
Guslandi, M. .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2007, 35 (05) :583-589
[54]   A CONTROLLED TRIAL OF PSYCHOLOGICAL TREATMENT FOR THE IRRITABLE-BOWEL-SYNDROME [J].
GUTHRIE, E ;
CREED, F ;
DAWSON, D ;
TOMENSON, B .
GASTROENTEROLOGY, 1991, 100 (02) :450-457
[55]   Attenuation of acute experimental colitis by preventing NPYY1 receptor signaling [J].
Hassani, H ;
Lucas, G ;
Rozell, B ;
Ernfors, P .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (03) :G550-G556
[56]   Role of Fcγ receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra [J].
He, Y ;
Le, WD ;
Appel, SH .
EXPERIMENTAL NEUROLOGY, 2002, 176 (02) :322-327
[57]   Autoantibody profiles in microscopic colitis [J].
Holstein, Andreas ;
Burmeister, Joerg ;
Plaschke, Armin ;
Rosemeier, Dirk ;
Widjaja, Adji ;
Egberts, Eick-Hartwig .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) :1016-1020
[58]   Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease [J].
Holzer, P .
DIGESTION, 1998, 59 (04) :269-283
[59]   Tachykinins in the gut .2. Roles in neural excitation, secretion and inflammation [J].
Holzer, P ;
HolzerPetsche, U .
PHARMACOLOGY & THERAPEUTICS, 1997, 73 (03) :219-263
[60]   Tachykinins in the gut .1. Expression, release and motor function [J].
Holzer, P ;
HolzerPetsche, U .
PHARMACOLOGY & THERAPEUTICS, 1997, 73 (03) :173-217